Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.

Abstract:

:Elevated plasma fibrinogen is a risk factor for cardiovascular disease (CVD), but associations between fibrinogen single nucleotide polymorphisms (SNPs) and disease risk are inconsistent. We investigated whether common (> or = 5% minor allele frequency) variation in the fibrinogen genes (FGA, FGB, FGG) is associated with fibrinogen concentration, carotid artery intima-medial thickness (IMT) and risk of incident myocardial infarction (MI), ischemic stroke and CVD mortality in European- (EA) and African-descent (AA) adults (> or = 65 years) from the Cardiovascular Health Study. TagSNPs were genotyped in 3,969 EA and 719 AA free of MI or stroke at baseline. Race-specific models included multiple testing correction and adjustment for sex, age and site. Among EA, minor alleles of FGA3807, FGB1437 and FGG902 were associated with higher fibrinogen levels; whereas FGA251, FGA2224, FGA6534 and FGG10034 were associated with lower levels, p<0.004 for each. Strongest associations were seen for FGB1437; each additional copy of the minor allele was associated with 13 mg/dl (95%CI: 9-16) higher fibrinogen level. Similar trends in AA were not significant. Fibrinogen haplotypes were not significantly associated with internal or common carotid IMT. No associations with MI or CVD mortality were seen in EA, though FGB1038 and FGG902 were significantly associated with increased and decreased risk of stroke in men, respectively, as were related haplotypes. FGB1038 was also associated with CVD mortality in AA, HR = 1.9 (95%CI: 1.3-2.7). In conclusion, while fibrinogen genetic variation was strongly associated with fibrinogen levels, there was less evidence of association with the more complex outcomes of IMT and CVD events.

journal_name

Thromb Haemost

authors

Carty CL,Cushman M,Jones D,Lange LA,Hindorff LA,Rice K,Jenny NS,Durda JP,Walston J,Carlson CS,Nickerson D,Tracy RP,Reiner AP

doi

10.1160/TH07-08-0523

subject

Has Abstract

pub_date

2008-02-01 00:00:00

pages

388-95

issue

2

eissn

0340-6245

issn

2567-689X

pii

08020388

journal_volume

99

pub_type

杂志文章,多中心研究
  • Bone morphogenetic protein 4 regulates microRNAs miR-494 and miR-126-5p in control of endothelial cell function in angiogenesis.

    abstract::MicroRNAs are small non-coding RNAs that negatively regulate posttranscriptional gene expression. Several microRNAs have been described to regulate the process of angiogenesis. Previously, we have shown that bone morphogenetic protein 4 (BMP4) increased the pro-angiogenic activity of endothelial cells. In this project...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH16-08-0643

    authors: Esser JS,Saretzki E,Pankratz F,Engert B,Grundmann S,Bode C,Moser M,Zhou Q

    更新日期:2017-04-03 00:00:00

  • Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka.

    abstract::The acidic mucopolysaccharide extracted from sea cucumber (Stichopus japonicus Selenka) (SJAMP) has been shown to cause platelets to aggregate. Using citrated platelet-rich plasma (PRP), washed platelets and formaldehyde-fixed platelets from humans, we investigated the effects of platelet inhibitors and various plasma...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Li JZ,Lian EC

    更新日期:1988-06-16 00:00:00

  • The basement membrane underlying the vascular endothelium is not thrombogenic: in vivo and in vitro studies with rabbit and human tissue.

    abstract::Studies examining the interaction of platelets with exposed subendothelium in vivo have reported conflicting results. To examine possible explanations for the apparently discrepant findings, we measured the platelet reactivity of subendothelium prepared by a number of methods both in vivo and in vitro. In addition, we...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Buchanan MR,Richardson M,Haas TA,Hirsh J,Madri JA

    更新日期:1987-08-04 00:00:00

  • Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients.

    abstract::The aim of the present study was to analyse differences in the protein expression profile between platelets from aspirin (ASA)-resistant patients and ASA-sensitive patients. We analysed platelets from 51 clinically stable coronary ischaemic patients taking ASA (100 mg/day) divided into ASA-resistant (n=25) and ASA-sen...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH09-05-0290

    authors: Mateos-Cáceres PJ,Macaya C,Azcona L,Modrego J,Mahillo E,Bernardo E,Fernandez-Ortiz A,López-Farré AJ

    更新日期:2010-01-01 00:00:00

  • Calcium electrode--a method for the continuous monitoring of the platelet release reaction.

    abstract::The calcium electrode is a convenient, inexpensive, and non-traumatic method for measuring changes in the extracellular calcium which accompanies a platelet release reaction. With this instrument, the temporal pattern of release by platelets in a buffered-saline medium following thrombin stimulation was observed as fo...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Robblee LS,Kornstein LB,Shepro D

    更新日期:1977-06-30 00:00:00

  • Low-dose warfarin in atrial fibrillation leads to more thromboembolic events without reducing major bleeding when compared to adjusted-dose--a meta-analysis.

    abstract::The use of warfarin with a range INR of 2.0-3.0 is recommended in prevention of stroke for nonvalvular atrial fibrillation (AF) patients, in particular those older than 75 years. The risk of bleeding that is associated with this range of INR has led to evaluate lower ranges (low-dose or fixed minidose) in terms of ris...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,meta分析

    doi:10.1160/TH03-08-0541

    authors: Perret-Guillaume C,Wahl DG

    更新日期:2004-02-01 00:00:00

  • TNK-tPA for acute myocardial infarction: the clinical experience.

    abstract::Thrombolytic therapy has become the mainstay of treatment for acute transmural myocardial infarction. Present fibrinolytic regimens have a number of shortcomings, including the failure to induce early and sustained reperfusion in as many as 40-50% of the patients, and to prevent reocclusion in another 10-20% of the pa...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Pislaru SV,Van de Werf F

    更新日期:1999-09-01 00:00:00

  • Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection.

    abstract::The Ig-ITIM superfamily member, PECAM-1 acts as a negative regulator of ITAM-signalling pathways in platelets involving GPVI/FcR gamma chain and Fc?RIIa. This negative feedback loop involves regulation of collagen and GPVI-dependent aggregation events, platelet-thrombus-growth on immobilised collagen under flow and Fc...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Sardjono CT,Harbour SN,Yip JC,Paddock C,Tridandapani S,Newman PJ,Jackson DE

    更新日期:2006-12-01 00:00:00

  • Prophylaxis in people with haemophilia.

    abstract::A four-decade clinical experience and recent evidence from randomised controlled studies definitively recognised primary prophylaxis, i.e. the regular infusion of factor concentrates started after the first haemarthrosis and/or before the age of two years, as the first-choice treatment in children with severe haemophi...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Coppola A,Franchini M,Tagliaferri A

    更新日期:2009-04-01 00:00:00

  • Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies.

    abstract::Seven mouse monoclonal antibodies have been produced against human melanoma tissue plasminogen activator (t-PA). They were specifically bound to 125I t-PA but not 125I urokinase (u-PA) and inhibited t-PA, but not u-PA, activity in plasminogen-rich 125I fibrin wells. Three of the antibodies directly inhibited the amido...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: MacGregor IR,Micklem LR,James K,Pepper DS

    更新日期:1985-02-18 00:00:00

  • Plasma concentration of von Willebrand factor in acute myocardial infarction.

    abstract::Recent investigations have revealed the crucial role of von Willebrand factor (vWF) in platelet thrombus formation under flow conditions. The plasma concentrations of vWF were measured together with various hemodynamic and hemostatic parameters in 51 cases of acute myocardial infarction. In 10 randomly selected cases,...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Sakai H,Goto S,Kim JY,Aoki N,Abe S,Ichikawa N,Yoshida M,Nagaoka Y,Handa S

    更新日期:2000-08-01 00:00:00

  • Binding of plasma von Willebrand factor by arterial microfibrils.

    abstract::We developed an ELISA test to measure the binding of plasma von Willebrand factor (vWF) to arterial microfibrils and compared this interaction to the binding of vWF to collagen under the same conditions. We found that vWF binds to microfibrils in a similar manner as it binds to collagen: the binding was independent of...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Fauvel-Lafève F,Legrand YJ

    更新日期:1990-08-13 00:00:00

  • Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.

    abstract::Factor IXa (FIXa) is a vitamin K-dependent coagulation serine protease which binds to factor VIIIa (FVIIIa) on negatively charged phospholipid vesicles (PCPS) to catalyse the activation of factor X (FX) to factor Xa (FXa) in the intrinsic pathway. Fluorescence resonance energy transfer (FRET) studies have indicated th...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH12-06-0436

    authors: Qureshi SH,Yang L,Rezaie AR

    更新日期:2012-12-01 00:00:00

  • Ultrasound thrombolysis.

    abstract::Cardiovascular diseases are a major cause of mortality in the developed world. Efficacy of thrombolysis plays an important role in the management of acute myocardial infarction and cerebral insult both in the acute event and in the long-term outcome of these patients. New adjunctive strategies have been tested, theref...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1160/TH04-12-0818

    authors: Pfaffenberger S,Devcic-Kuhar B,Kastl SP,Huber K,Maurer G,Wojta J,Gottsauner-Wolf M

    更新日期:2005-07-01 00:00:00

  • The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.

    abstract::Thrombin incubated with 2,3-diphosphoglycerate (150 nmol 2,3-DPG/1 NIH thrombin unit) lost up to 70% of its clotting activity, whereas the esterase activity remained unchanged. No fibrinopeptide release by thrombin was observed in the presence of 2,3-DPG. The fibrin polymerization was normal. By chromatography on Ambe...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Del Principe D,Strappini PM,Del Vecchio S,Menichelli A,Biancini G,Cosmi EV,Bastianon V,D'Arcangelo C

    更新日期:1981-10-01 00:00:00

  • Participation of Hageman factor dependent pathways in human disease states.

    abstract::Abnormalities of Hageman factor dependent pathways have been described in a wide variety of human disease states. Congenital deficiencies of factor XII (Hageman trait) prekallikrein (Fletcher trait) and high molecular weight kininogen (Williams, Fitzgerald and Flaujeac traits) although resulting in profound in vitro c...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Colman RW,Wong PY

    更新日期:1977-12-15 00:00:00

  • The factor VIII bypassing activity of prothrombin complex concentrates: the roles of factor VIIa and of endothelial cell tissue factor.

    abstract::An experimental model incorporating cultured endothelial cells (EC) was used to study the "factor VIII bypassing" activity of prothrombin complex concentrates (PCC), a property exploited in the treatment of hemophiliacs with alloantibodies to factor VIII. Two PCC preparations were ineffective as stimuli of tissue fact...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Teitel JM

    更新日期:1991-11-01 00:00:00

  • Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence.

    abstract::Despite great efforts in stroke research, disability and recurrence rates in ischaemic stroke remain unacceptably high. To address this issue, one potential target for novel therapeutics is the glycoprotein von Willebrand factor (vWF), which increases in thrombogenicity especially under high shear rates as it bridges ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1648251

    authors: Buchtele N,Schwameis M,Gilbert JC,Schörgenhofer C,Jilma B

    更新日期:2018-06-01 00:00:00

  • Heparan sulfate-protein interactions--a concept for drug design?

    abstract::The glycosaminoglycan, heparan sulfate (HS) is composed of alternating units of hexuronic acid and glucosamine, that are variously sulfate-substituted at different positions. Proteoglycans carrying HS chains are ubiquitously expressed at cell surfaces and in the extracellular matrix. The structures of these chains are...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Lindahl U

    更新日期:2007-07-01 00:00:00

  • Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations.

    abstract::Platelet-monocyte aggregates are increasingly being used to quantify platelet activation. The variables that influence platelet-monocyte aggregates have not been well defined. We sought to determine the effect of blood collection, handling and processing techniques on detected levels of platelet-monocyte aggregates us...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Harding SA,Din JN,Sarma J,Jessop A,Weatherall M,Fox KA,Newby DE

    更新日期:2007-08-01 00:00:00

  • Concomitant secretion by A431 cells of tissue plasminogen activator and a specific inhibitor masks EGF modulation of tPA activity.

    abstract::It has previously been reported that EGF enhances uPA but not tPA in the A431 squamous carcinoma cell line. To determine whether the absence of tPA modulation by EGF reflected steady levels or the action of an anti-activator, we assayed tPA, PAI-1 and tPA/PAI-1 complexes by zymography and immunological assays. Under c...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: George F,Pourreau-Schneider N,Arnoux D,Boutière B,Berthois Y,Martin PM,Sampol J

    更新日期:1990-11-30 00:00:00

  • Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers.

    abstract::Sulodexide, a highly purified glycosaminoglycan, was investigated for treatment of venous leg ulcers. Patients (n = 235) undergoing local treatment including wound care and compression bandaging, were randomised to receive either sulodexide or matching placebo for three months. Primary study endpoint was complete ulce...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Coccheri S,Scondotto G,Agnelli G,Aloisi D,Palazzini E,Zamboni V,Venous arm of the SUAVIS (Sulodexide Arterial Venous Italian Study) Group.

    更新日期:2002-06-01 00:00:00

  • Cyclic nucleotides in platelet function.

    abstract::Inhibition of adenylate cyclase in intact platelets by addition of compounds such as 2', 5' - dideoxyadenosine prevented the inhibition of platelet aggregation by PGE1 but did not affect the responses of platelets to aggregating agents in the absence of PGE1. This confirms that cyclic AMP mediates the effects of PGE1 ...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章,评审

    doi:

    authors: Haslam RJ,Davidson MM,Fox JE,Lynham JA

    更新日期:1978-10-31 00:00:00

  • Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.

    abstract::Components of the fibrinolytic system were studied in samples of plasma from 15 normal, young women and from 11 women taking oral contraceptives containing 30 micrograms ethinyl oestradiol and 150 micrograms levo-norgestrel. Fibrinolytic activity of euglobulins precipitated at pH 5.9 was higher than normal in the horm...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Jespersen J,Kluft C

    更新日期:1985-08-30 00:00:00

  • Redistribution of platelet glycoproteins induced by allo- and autoantibodies.

    abstract::The redistribution of platelet glycoproteins (GP) Ib, IIb and IIIa in response to stimulation with human platelet specific alloantibodies, autoantibodies and a quinidine-dependent antibody was investigated using immunofluorescence and a quantitative radioimmunoassay. The platelet GPs carrying the corresponding epitope...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Santoso S,Kiefel V,Mueller-Eckhardt C

    更新日期:1987-10-28 00:00:00

  • Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala.

    abstract::We have identified a patient with a dysfunctional prothrombin that we have designated Prothrombin Frankfurt. The proband was characterized by a prothrombin activity level of 13% and 20% compared to normal controls using two different assays with a normal prothrombin antigen level of 91% of normal controls. The genetic...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:

    authors: Degen SJ,McDowell SA,Sparks LM,Scharrer I

    更新日期:1995-02-01 00:00:00

  • Increased thrombin generation in persons with echogenic carotid plaques.

    abstract::Echolucent carotid plaques are associated with higher risk for future ischemic cerebrovascular events (CVE) than echogenic plaques independent of the degree of stenosis. Elevated markers of thrombin generation are associated with atherosclerotic plaques and are increased in the acute and chronic phases of CVE. The pre...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH07-08-0493

    authors: With Notø AT,Mathiesen EB,Østerud B,Amiral J,Vissac AM,Hansen JB

    更新日期:2008-03-01 00:00:00

  • Genetic contribution to variation in atherothrombotic phenotypes in the Asian Indian population. The Indian Atherosclerosis Research Study.

    abstract::Coronary artery disease (CAD) is a multifactorial disease, and family history is the best available tool to assess gene-environment interaction. This study addressed the heritability of quantitative traits, namely lipid, coagulation/fibrinolysis and pro-inflammatory markers in the ongoing family-based Indian Atheroscl...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH08-01-0018

    authors: Rao VS,Khadrinarasimhaih NB,Kanjilal S,Mukerjee M,Kakkar VV

    更新日期:2009-08-01 00:00:00

  • Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.

    abstract::An association has been reported between thrombotic events and the use of L-asparaginase (ASP) in children with acute lymphoblastic leukaemia (ALL). The mechanism for thrombosis is likely related to an acquired antithrombin deficiency. Since a primary prophylaxis using antithrombin concentrates may prevent thrombosis,...

    journal_title:Thrombosis and haemostasis

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1160/TH02-11-0283

    authors: Mitchell L,Andrew M,Hanna K,Abshire T,Halton J,Wu J,Anderson R,Cherrick I,Desai S,Mahoney D,McCusker P,Chait P,Abdolell M,de Veber G,Mikulis D

    更新日期:2003-08-01 00:00:00

  • The unsialylated subpopulation of recombinant activated factor VII binds to the asialo-glycoprotein receptor (ASGPR) on primary rat hepatocytes.

    abstract::Recombinant activated factor VII (rFVIIa; NovoSeven®) is a heterogeneously glycosylated serine protease used for treatment of haemophiliacs with inhibitors. The drug substance contains a subpopulation consisting of ~20% of rFVIIa molecules which are unsialylated and consists of carbohydrate moieties with terminally ex...

    journal_title:Thrombosis and haemostasis

    pub_type: 杂志文章

    doi:10.1160/TH10-06-0356

    authors: Seested T,Nielsen HM,Christensen EI,Appa RS

    更新日期:2010-12-01 00:00:00